What is a peptide?
Let us start with the word itself. A peptide is a short chain of amino acids. Amino acids are the building blocks of proteins — think of them as beads, and a protein as a long necklace of those beads. A peptide is just a much shorter string of the same beads.
So the simple difference is size: a peptide is a small chain, and a protein is a big one. Same kind of building blocks, fewer of them.
Here is the part that surprises people: your body already makes lots of peptides on its own. Many of the hormones your body uses every day are peptides. A hormone is a chemical messenger that travels in your blood and tells one part of your body what another part is doing. So peptides are not strange or foreign — they are a normal part of how your body talks to itself.
What does "peptide therapy" actually mean?
"Peptide therapy" simply means using peptide-based compounds as medicine. Because your body already speaks the language of peptides, scientists can make peptide-based drugs that step into that same conversation — copying a natural messenger, or blocking one.
But here is the single most important thing to understand, and it is the reason this page exists: "peptide therapy" is not one thing. It is a giant umbrella term that covers a huge range of very different compounds.
At one end of that range are medicines that have been tested for years in large studies and approved by the FDA — the part of the United States government that checks whether a medicine is safe and whether it actually works. At the other end are compounds that have barely been tested in people at all, or not at all. They are all called "peptides," but the proof behind them is worlds apart.
So when someone says "peptide therapy," the honest first question is always: which peptide, exactly? Because the answer changes everything about how much we really know.
It is also worth saying what "peptide therapy" is not. It is not a single treatment you can judge with one thumbs-up or thumbs-down. It is not a promise that something is natural, gentle, or safe just because your body also makes peptides — plenty of powerful and even dangerous substances are perfectly natural. And it is not a guarantee that a compound has been tested at all. The word describes a type of molecule, nothing more. Everything that matters — does it work, is it safe, is it even legal to prescribe — depends on the specific compound, not on the shared label.
Which peptide therapies actually have strong evidence?
The clearest examples of peptide medicines with strong proof are the GLP-1 drugs — the well-known weight and diabetes medicines.
GLP-1 is short for glucagon-like peptide-1. It is a hormone your gut releases after you eat. It does two main jobs: it lowers your appetite, and it tells your stomach to empty more slowly, so you feel full for longer. The GLP-1 medicines are man-made copies of that natural signal, built to last much longer than the brief one your body makes on its own.
Two of these are FDA-approved and very well studied. The first is semaglutide. In a large study, people taking it lost about 14.9 percent of their body weight on average — close to one-seventh of their starting weight. The second is tirzepatide, which copies GLP-1 plus a second gut signal. In its large study, people lost about 20.9 percent of their body weight on average — roughly one-fifth.
Those are not small numbers, and they did not come from guesswork. They came from large trials in real people, and the medicines were then reviewed and approved. This is what the strong end of "peptide therapy" looks like: clear human evidence, a known safety picture, and an official approval behind it.
It is worth being clear about what "FDA-approved" actually buys you, because it sits at the heart of this whole topic. To earn approval, a medicine has to be tested in large groups of people, have its results checked by outside reviewers, and have its risks weighed openly against its benefits. The right dose, the warnings, and the people who should not take it all get written into an official label that regulators sign off on. That is a high bar, and most things sold as "peptides" have never come close to clearing it. When a peptide has cleared it, that genuinely means something — and it is worth keeping firmly separate from everything that has not.
Which peptide therapies are still experimental or unproven?
Now the other end of the range — and this is where honesty matters most. Many things sold or discussed as "peptide therapy" do not have that kind of proof. The evidence varies enormously from one compound to the next, and for some it is thin or missing entirely.
There are really two different situations here, and it helps to keep them apart.
The first is investigational compounds — ones that are still being formally tested in studies but are not approved yet. A good example is retatrutide. It copies three gut signals at once instead of one or two, and early studies have looked promising to scientists. But it is still being tested and is NOT FDA-approved. "Still being studied" and "approved for use" are very different things. Promising in a trial is not the same as proven and cleared for everyday use.
The second situation is the many compounds often called "research peptides" — things you may see sold online, such as BPC-157 and others. These are not FDA-approved, and for many of them there is little or no completed human-trial evidence at all. That is the honest status, and it is worth being plain about: when a compound has not been properly tested in people, nobody can tell you it works or that it is safe. Not knowing is itself the answer, and an honest one.
None of this is meant to scare anyone or to say "peptides are bad." The point is the opposite of a blanket label. There is no single verdict for the whole category. A peptide with years of large human trials behind it and a peptide with none are simply not in the same conversation, even though they share a name.
What kinds of peptide medicines are there?
It helps to know that the approved peptide medicines are not one drug, or even one type. Scientists count more than eighty peptide-based drugs approved around the world, used across many different areas of medicine — not only weight and blood sugar, but also hormone conditions, bone health, and more. More than a hundred and seventy others are still being studied in trials. So "peptide medicine" is itself a broad shelf, not a single product.
The GLP-1 drugs are the most famous example, simply because so many people take them. But they are only one family. Another approved example is tesamorelin. It is a man-made copy of a natural signal that nudges the body to release its own growth hormone, and it is approved for a very specific job: reducing a particular kind of deep belly fat in people living with HIV. In its main trial, that deep fat fell by about 15 percent on the medicine while it slightly rose on a dummy treatment. Notice how narrow that is — one compound, one clearly defined use, one body of studies behind it.
That narrowness is the pattern, not the exception. Approved peptides tend to be cleared for one specific purpose, tied to one specific set of evidence. What links them together is not the word "peptide" — it is the testing and the official review behind each one. That is the real dividing line in this whole topic: not the chemistry, but the proof.
| Example peptide | What it does | Regulatory status |
|---|---|---|
| Semaglutide (GLP-1) | Copies a gut hormone that lowers appetite; ~14.9% average body-weight loss in its trial | FDA-approved |
| Tirzepatide (GLP-1 + a second gut signal) | ~20.9% average body-weight loss at the highest dose in its trial | FDA-approved |
| Tesamorelin (growth-hormone-releasing analog) | Cut deep belly (visceral) fat ~15% in people living with HIV | FDA-approved (HIV-related fat only) |
| Retatrutide (triple gut-hormone agonist) | Looked promising for weight loss in an early study | Investigational — NOT FDA-approved |
| "Research peptides" (e.g. BPC-157) | Marketed for healing or recovery, but little or no completed human-trial evidence | Not FDA-approved |
Are peptide medicines only for weight loss?
Because the GLP-1 weight medicines are everywhere right now, it is easy to assume "peptide therapy" basically means weight loss. It does not. Even inside the approved GLP-1 group, the proven effects reach well past the bathroom scale.
Here is one example. In a large study of people who were overweight and already had heart disease, semaglutide lowered the chance of a serious heart problem — things like a heart attack or a stroke — by about 20 percent compared with a dummy treatment. That is a completely different kind of benefit from weight loss, measured in a different way, and it showed up even in people who did not have diabetes. It came from a long trial in many thousands of real patients, which is what turns it into a finding rather than a hope.
Other approved peptides do other narrow jobs entirely — the tesamorelin example above targets one specific kind of deep belly fat in one specific group of patients, and nothing else. So the honest takeaway is not "peptides do everything." It is closer to the opposite. Each approved peptide has its own specific, tested use, and that use does not transfer to a different compound just because both happen to be called peptides. A proven job for one peptide is not a proven job for the whole category.
How to think about it safely
If you take one idea away, let it be this: never judge "peptide therapy" as a whole. Ask about the specific compound in front of you, and ask what evidence actually backs it.
A few plain questions go a long way. Is this compound FDA-approved, still being studied, or neither? Has it actually been tested in people, or only talked about? What is the real proof, in human studies, that it does what someone claims? If the honest answer is "we do not really know yet," that is important information, not a detail to skip past.
And this is exactly the kind of decision to make with a licensed clinician — a doctor or other qualified medical professional — who knows your full health history. A good clinician can tell you where a specific compound sits on that range from well-proven to unproven, what is actually known, and what is still a question mark. This page is here to explain ideas in plain words, not to give you medical advice or to tell you what to take.
Keeping track of it all with PeptidePanel
If a clinician does put you on a peptide-based medicine, there is real day-to-day stuff to keep track of: when your next dose is due, how you are feeling over time, and the lab numbers your clinician watches. That is easy to lose track of in your head.
PeptidePanel is a simple tracking tool for exactly that. It records the plan your clinician set, charts your results over time, and reminds you when something is due. It works the same whether the plan involves an FDA-approved medicine or a compound your clinician is supervising more carefully.
One thing it does not do: PeptidePanel does not sell, supply, prescribe, or recommend any compound — approved or not. It is just the notebook that keeps your clinician's plan organized for you, so the conversations you have with them are clearer.